Lv1
40 积分 2025-07-08 加入
Homologous recombination deficiency in endometrial cancer: shedding light on recent clinical findings
22小时前
求助中
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis
22小时前
已完结
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients
26天前
已完结
Chemoprevention or mastectomy for women at high risk of developing breast cancer
26天前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
29天前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
29天前
已完结
[Association analysis on BRCA gene functional domain mutations and prognosis in patients with ovarian epithelial carcinoma and fallopian tube carcinoma]
1个月前
已完结
[Chinese clinical practice guideline for genetic testing in advanced breast cancer (2025 edition)]
2个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
3个月前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
3个月前
已完结
皖公网安备34019202002308
